Evidence map›Paper›PMID 31423480›Full record

ArticleNature metabolism2019

Increased β-cell proliferation before immune cell invasion prevents progression of type 1 diabetes.

Ercument Dirice, Sevim Kahraman, Dario F De Jesus, Abdelfattah El Ouaamari, Giorgio Basile, Rocky L Baker, Burcu Yigit, Paul D Piehowski, Mi-Jeong Kim, Alexander J Dwyer and 14 more

Abstract read
In one paragraph

Article in Nature metabolism, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed, 1 pooled it
6.6field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 1 synthesis or guideline pooled it, 49 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Redox regulation of mNature cell biology · 2024
    Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Pancreatic β-Cell Development and Regeneration.Cold Spring Harbor perspectives in biology · 2022
    Review
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors at 6 institutions in 2 countries.

Ercument DiriceIslet Cell and Regenerative Biology, Joslin Diabetes Center, Boston, MA, USA.
Sevim KahramanIslet Cell and Regenerative Biology, Joslin Diabetes Center, Boston, MA, USA.
Dario F De JesusIslet Cell and Regenerative Biology, Joslin Diabetes Center, Boston, MA, USA.
Abdelfattah El OuaamariIslet Cell and Regenerative Biology, Joslin Diabetes Center, Boston, MA, USA.
Giorgio BasileIslet Cell and Regenerative Biology, Joslin Diabetes Center, Boston, MA, USA.
Rocky L BakerDepartment of Immunology, School of Medicine, University of Colorado, Aurora, CO, USA.
Burcu YigitDivision of Immunology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.
Paul D PiehowskiBiological Sciences Division, Pacific Northwest National Laboratory, Richland, WA, USA.
Mi-Jeong KimSection for Immunobiology, Joslin Diabetes Center, Boston, MA, USA.
Alexander J DwyerUniversity of Minnesota, Center for Immunology, Department of Medicine, Minneapolis, MN, USA.
Raymond W S NgIslet Cell and Regenerative Biology, Joslin Diabetes Center, Boston, MA, USA.
Cornelia SchusterSection for Immunobiology, Joslin Diabetes Center, Boston, MA, USA.
Heidrun VetheIslet Cell and Regenerative Biology, Joslin Diabetes Center, Boston, MA, USA.
Tijana MartinovUniversity of Minnesota, Center for Immunology, Department of Medicine, Minneapolis, MN, USA.
Yuki IshikawaSection for Immunobiology, Joslin Diabetes Center, Boston, MA, USA.
Adrian Kee Keong TeoIslet Cell and Regenerative Biology, Joslin Diabetes Center, Boston, MA, USA.
Richard D SmithBiological Sciences Division, Pacific Northwest National Laboratory, Richland, WA, USA.
Jiang HuIslet Cell and Regenerative Biology, Joslin Diabetes Center, Boston, MA, USA.
Kathryn HaskinsDepartment of Immunology, School of Medicine, University of Colorado, Aurora, CO, USA.
Thomas SerwoldSection for Immunobiology, Joslin Diabetes Center, Boston, MA, USA.
Wei-Jun QianBiological Sciences Division, Pacific Northwest National Laboratory, Richland, WA, USA.
Brian T FifeUniversity of Minnesota, Center for Immunology, Department of Medicine, Minneapolis, MN, USA.
Stephan KisslerSection for Immunobiology, Joslin Diabetes Center, Boston, MA, USA.
Rohit N KulkarniIslet Cell and Regenerative Biology, Joslin Diabetes Center, Boston, MA, USA.
Brigham and Women's Hospital · USJoslin Diabetes Center · USPacific Northwest National Laboratory · USUniversity of Minnesota · USUniversity of Colorado Anschutz Medical Campus · USBeth Israel Deaconess Medical Center · US

Funding

SPECIAL ASSAY COREP30DK036836 · NIDDK · JOSLIN DIABETES CENTER · PI ROHIT N. KULKARNI · 1986 to 2026
$50.5M
Equipment Supplement Request for a Research Resource for Ultra-sensitive High Throughput ProteomicsP41GM103493 · NIGMS · BATTELLE PACIFIC NORTHWEST LABORATORIES · PI SMITH, RICHARD D · 2012 to 2022
$22.6M
Role of IGF-1 and Insulin Receptors Beta-Cell SurvivalR01DK067536 · NIDDK · JOSLIN DIABETES CENTER · PI ROHIT N. KULKARNI · 2004 to 2026
$8.0M
Hybrid Peptides as Autoantigens for Diabetogenic CD4 T CellsR01DK081166 · NIDDK · UNIVERSITY OF COLORADO DENVER · PI HASKINS, KATHRYN M, JAMES, EDDIE A · 2011 to 2024
$7.3M
Regulatory Networks and Biomarkers of Beta-cell Dysfunction and ApoptosisUC4DK104167 · NIDDK · BATTELLE PACIFIC NORTHWEST LABORATORIES · PI KULKARNI, ROHIT N., MATHEWS, CLAYTON E · 2014 to 2016
$2.7M
Role of SerpinB1 in beta cell growthR01DK103215 · NIDDK · JOSLIN DIABETES CENTER · PI KULKARNI, ROHIT N. · 2014 to 2018
$2.6M
Mechanisms of immune tolerance in autoimmune diabetesR01AI106791 · NIAID · UNIVERSITY OF MINNESOTA · PI FIFE, BRIAN T · 2014 to 2018
$1.9M
T cells reactive to Hybrid Insulin Peptides (HIPs) as biomarkers in autoimmune diabetesR21AI133059 · NIAID · UNIVERSITY OF COLORADO DENVER · PI BAKER, ROCKY LEE · 2018 to 2019
$428k
NIAID NIH HHS R01 AI106791NIAID NIH HHS R21 AI133059NIDDK NIH HHS P30 DK036836NIDDK NIH HHS R01 DK067536NIDDK NIH HHS R01 DK081166NIDDK NIH HHS R01 DK103215NIDDK NIH HHS UC4 DK104167NIGMS NIH HHS P41 GM103493
6 · The paper itself

Abstract

Type 1 diabetes (T1D) is characterized by pancreatic islet infiltration by autoreactive immune cells and a near-total loss of β-cells

Indexed as

Cell ProliferationAnimalsDiabetes Mellitus, Type 1Disease ProgressionHumansImmune SystemInsulin-Secreting CellsMice

Identifiers

PMID31423480
PMCPMC6696912
OpenAlexW2943548597

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.